RobertRMontgomeryMD

PubMed

• Prevalence and characterization of anti-VWF antibodies in a population of patients with type 3 VWD.
  Crystal L Perry, Pamela A Christopherson, Tina A Agostini, Sandra L Haberichter, Robert R Montgomery
  Blood Advances. 2024-10-08
• 1 citations
  The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change.
  Pamela A Christopherson, Nathalie Tijet, Sandra L Haberichter, Veronica H Flood, Justyne Ross
  Journal of Thrombosis and Haemostasis. 2024-03-01
• 1 citations
  Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD.
  Jonathan C Roberts, Pamela A Christopherson, Michael D Tarantino, Sarah E Gonzales, Patti A Morateck
  Haemophilia. 2024-01-01

Journal Articles

• An International Collaborative Study by Expert Centres to Compare Results from Different Von Willebrand Factor Glycoprotein Ib Binding Activity Assays  
  Y Liu, R Montgomery, Journal of Thrombosis and Haemostasis
• Markers of vascular perturbation correlate with airway structural change in asthma  
  Johansson,M.W., Kruger,S.J., Schiebler,M.L., Evans,M.D., Sorkness,R.L., Denlinger,L.C., Busse,W.W., Jarjour,N.N., Montgomery,R.R., Mosher,D.F. et al, Am. J. Respir. Crit Care Med, 7/15/2013
• The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels  
  Rydz,N., Swystun,L.L., Notley,C., Paterson,A.D., Riches,J.J., Sponagle,K., Boonyawat,B., Montgomery,R.R., James,P.D., and Lillicrap,D., Blood, 6/27/2013
• Collagen binding provides a sensitive screen for variant von Willebrand disease  
  Flood,V.H., Gill,J.C., Friedman,K.D., Christopherson,P.A., Jacobi,P.M., Hoffmann,R.G., Montgomery,R.R., Haberichter,S.L., and Zimmerman Program, Clin. Chem, 4/1/2013
• Third Aland islands Conference on von Willebrand disease, 26-28 September 2012: Meeting report  
  Berntorp,E., Fuchs,B., Makris,M., Montgomery,R., Flood,V., O'Donnell,J.S., Federici,A.B., Lillicrap,D., James,P., Budde,U. et al, Haemophilia, 1/1/2013
• Factor VIII inhibitors: von willebrand factor makes a difference in vitro and in vivo  
  Shi,Q., Kuether,E.L., Schroeder,J.A., Perry,C.L., Fahs,S.A., Cox,G.J., and Montgomery,R.R., J. Thromb. Haemost., 11/1/2012
• Lentivirus-mediated platelet gene therapy of murine hemophilia A with pre-existing anti-factor VIII immunity  
  Kuether,E.L., Schroeder,J.A., Fahs,S.A., Cooley,B.C., Chen,Y., Montgomery,R.R., Wilcox,D.A., and Shi,Q., J. Thromb. Haemost., 8/1/2012
• Contribution of platelet vs endothelial VWF to platelet adhesion and hemostasis  
  Kanaji,S., Fahs,S.A., Shi,Q., Haberichter,S.L., and Montgomery,R.R., J. Thromb. Haemost., 8/1/2012
• Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease  
  Flood,V.H., Gill,J.C., Christopherson,P.A., Wren,J.S., Friedman,K.D., Haberichter,S.L., Hoffmann,R.G., and Montgomery,R.R., J. Thromb. Haemost., 7/1/2012
• Critical von Willebrand factor A1 domain residues influence type VI collagen binding  
  Flood,V.H., Gill,J.C., Christopherson,P.A., Bellissimo,D.B., Friedman,K.D., Haberichter,S.L., Lentz,S.R., and Montgomery,R.R., J. Thromb. Haemost., 7/1/2012
• Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316)  
  Hubbard,A.R., Hamill,M., Eikenboom,H.C., Montgomery,R.R., Mertens,K., Haberichter,S., and SSC sub-committee on von Willebrand factor of ISTH, J. Thromb. Haemost., 5/1/2012
• VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population  
  Bellissimo,D.B., Christopherson,P.A., Flood,V.H., Gill,J.C., Friedman,K.D., Haberichter,S.L., Shapiro,A.D., Abshire,T.C., Leissinger,C., Hoots,W.K. et al, Blood, 1/1/2012
• von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion  
  Madabhushi,S.R., Shang,C., Dayananda,K.M., Rittenhouse-Olson,K., Murphy,M., Ryan,T.E., Montgomery,R.R., and Neelamegham,S., Blood, 1/1/2012
• Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy  
  Kanaji,S., Kuether,E.L., Fahs,S.A., Schroeder,J.A., Ware,J., Montgomery,R.R., and Shi,Q., Mol. Ther., 1/1/2012
• Platelet and endothelial expression of clotting factors for the treatment of hemophilia  
  Montgomery,R.R., and Shi,Q., Thromb. Res., 1/1/2012
• Characterization of zebrafish von Willebrand factor reveals conservation of domain structure, multimerization, and intracellular storage  
  Ghosh,A., Vo,A., Twiss,B.K., Kretz,C.A., Jozwiak,M.A., Montgomery,R.R., and Shavit,J.A., Adv. Hematol, 1/1/2012
• von Willebrand's disease: a report from a Meeting in the Aland islands  
  Berntorp,E., Peake,I., Budde,U., Laffan,M., Montgomery,R., Windyga,J., Goodeve,A., Petrini,P., von,D.M., Miesbach,W. et al, Haemophilia, 1/1/2012
• Von Willebrand disease in the United States: a perspective from Wisconsin  
  Flood,V.H., Gill,J.C., Friedman,K.D., Bellissimo,D.B., Haberichter,S.L., and Montgomery,R.R., Semin. Thromb. Hemost., 1/1/2011
• Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD  
  Flood,V.H., Lederman,C.A., Wren,J.S., Christopherson,P.A., Friedman,K.D., Hoffmann,R.G., and Montgomery,R.R., J. Thromb. Haemost., 1/1/2010
• von Willebrand's disease diagnosis and laboratory issues  
  Castaman,G., Montgomery,R.R., Meschengieser,S.S., Haberichter,S.L., Woods,A.I., and Lazzari,M.A., Haemophilia, 1/1/2010
• Platelets as delivery systems for disease treatments  
  Shi,Q., and Montgomery,R.R., Adv. Drug Deliv. Rev., 1/1/2010
• Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage  
  Haberichter,S.L., Allmann,A.M., Jozwiak,M.A., Montgomery,R.R., and Gill,J.C., J. Thromb. Haemost., 1/1/2009
• Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines  
  Nichols,W.L., Rick,M.E., Ortel,T.L., Montgomery,R.R., Sadler,J.E., Yawn,B.P., James,A.H., Hultin,M.B., Manco-Johnson,M.J., and Weinstein,M., Am. J. Hematol., 1/1/2009
• Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function  
  Flood,V.H., Friedman,K.D., Gill,J.C., Morateck,P.A., Wren,J.S., Scott,J.P., and Montgomery,R.R., J. Thromb. Haemost., 1/1/2009
• Type 2B von Willebrand disease associated with the release of platelet agglutinates from megakaryocytes in the bone marrow  
  Slayton,W.B., Patel,M., Sola-Visner,M., Harris,N., Rivers,A., Montgomery,R.R., and Friedman,K.D., J. Pediatr. Hematol. Oncol., 1/1/2008
• Join now to see all

Books/Book Chapters

• Nelson's Textbook of Pediatrics 
  Chapter: Hemorrhagic and Thrombotic Disorders. 
  Page 467 - 482Scott JP, Montgomery RREditors: Behrman RE, Kliegman RM, Jenson HB.WB Saunders, PhiladelphiaEdition 18th,2007
• Hemostasis and Thrombosis-Basic Principles and Clinical Practice 
  Chapter: Structure and Function of von Willebrand Factor. 
  Page 707 - 722Haberichter SL, Montgomery RREditors: Coleman, Marder, Clowes, George, and Goldhaber.Lippincott, Williams, Wilkins, Philadelphia, PAEdition 5th,2005
• Nelson's Textbook of Pediatrics 
  Chapter: Hemorrhagic and Thrombotic Diseases. 
  Page 1651 - 1674Montgomery RR, Scott JPEditors: Behrman RE, Kliegman RM, Jenson HB.WB Saunders, PhiladelphiaEdition 17th,2004
• Hemostasis and Thrombosis: Basic Principles and Clinical Practice 
  Chapter: "Structure and Function of Von Willebrand Factor" 
  Page 249 - 274Montgomery RREditors: Colman, Hirsh, Marder, Clowes, George.Lippincott Williams WilkinsEdition 4th,2001
• Textbook of Pediatrics 
  Chapter: Hemorrhagic and Thrombotic Diseases. 
  Page 1504 - 1525Montgomery RR, Scott JPEditors: Behrman RE, Kliegman RM, Jenson HB.WB Saunders, PhiladelphiaEdition 16th,2000
• Disorders of Hemostasis and Thrombosis: A Clinical Guide 
  Chapter: von Willebrand Disease. 
  Montgomery, R.R.Editors: S.H. Goodnight, W.E. Hathaway.McGraw-Hill, Inc., New York2000
• Hematology: Basic Principles and Practice 
  Chapter: Clinical Aspects of and Therapy for von Willebrand Disease. 
  Page 1946 - 1958White II GC, Montgomery RREditors: R. Hoffman, EJ Benz Jr, SJ Shattil, B Furie, HJ Cohen, LE Silberstein, P McGlave.Churchill Livingstone, Philadelphia1999
• Hematology of Infancy and Childhood 
  Chapter: Hemophilia and von Willebrand Disease. 
  Montgomery, RR, Gill, JC, Scott, JPEditors: Nathan, Orkin, Oski.WB Saunders, Philadelphia, PA1998
• Diagnosis and Management of Severe von Willebrand Disease (Types 2 and 3) 
  Chapter: The molecular basis of von Willebrand Disease. 
  Page 15 - 25Kroner PA, Montgomery RREditors: WK Hoots.Advanstar, Philadelphia, PA1996
• Hematology: Basic Principles and Practice 
  Chapter: Clinical aspects and therapy of von Willebrand Disease. 
  Page 1725 - 1736White GC, Montgomery RRChurchill Livingstone, Inc., New York, NYEdition 2nd,1994
• Hematology 
  Chapter: Preparation and clinical use of plasma and plasma fractions. 
  Menitove JE, Gill JC, Montgomery RRMcGraw-Hill, New York, NYEdition 5th,1994
• Hematology of Infancy and Childhood 
  Chapter: Principles of therapy for hemostasis factor deficiencies. 
  Page 1796 - 1818Gill JC, Montgomery RREditors: Nathan and Oski.W.B. Saunders, Philadelphia, PAEdition 4th,1993
• Hemostasis and Thrombosis, Basic Principles and Clinical Practice 
  Chapter: von Willebrand disease. 
  Page 134 - 168Montgomery RR, Coller BSEditors: R Colman, J Hirsh, V Marder, E Salzman.1993
• Hematology of Infancy and Childhood 
  Chapter: Hemostasis: Diseases of The Fluid Phase. 
  Page 1605 - 1650Montgomery RR, Scott JPEditors: Nathan and Oski.W.B. Saunders, Philadelphia, PAEdition 4th,1993
• Hematology: Basic Principles and Practice. 
  Chapter: Clinical aspects and therapy of von Willebrand's Disease. 
  Page 1362 - 1372White GC, Montgomery RREditors: Hoffman, Benz, Shattil, Furrie, Cohen.Churchill Livingstone, Inc., New York, NY1991
•  
  Chapter: Screening of lambda gt11 libraries. 
  Friedman KD, Rosen NL, Newman PJ, Montgomery RREditors: Innis M, Gelfand D, Sninsky J, White T.Academic Press, Orlando, FL1989
• The Polymerase Chain Reaction; Current Communications in Molecular Biology 
  Chapter: Human von Willebrand's disease. Analysis of platelet mRNA by PCR. 
  Ginsburg D, Konkle BA, Gill JC, Montgomery RR, Bockenstedt PL, Johnson TA, Yang AY1989
• Hemophilia in the Child and Adult 
  Chapter: Musculoskeletal problems in Hemophilia. 
  Page 27 - 43Gill JC, Thometz J, Scott JP, Montgomery RREditors: M Hilgartner, C. Pochedly.Raven Press1989
• Smith's Blood Diseases of Infancy and Childhood 
  Chapter: von Willebrand's disease. 
  Montgomery RR, Corrigan JJEditors: C.V. Mosby, Inc..Edition 6th,1989
• Platelet Immunology 
  Chapter: Homologous Functions and Interactions of Platelets and Endothelial Cells. 
  Page 255 - 272Montgomery RR, Scott JPEditors: TJ Kunicki, JN George.J.B. Lippincott Company, Philadelphia1989
• Bertina: Protein C and Related Proteins 
  Chapter: Homozygous protein C deficiency. 
  Page 182 - 195Marlar RA, Montgomery RR, Madden RMChurchill Livingstone1987
•  
  Page 201 - 218Kunicki TJ, Newman PJ, Montgomery RR, Kawai Y, Furihata K1986
• Monoclonal Antibodies and Human Blood Platelets 
  Chapter: Polyclonal and monoclonal antibodies used in the rapid detection of platelet defects. 
  Page 297 - 305Kunicki TJ, Montgomery RR, Kristopeit SMEditors: J. McGregor.Elsevier Science Publishers, Amsterdam1986
• Current Pediatric Therapy 
  Page 399 - 403Montgomery RR, McIntosh RMEditors: Gilles, Kagan.WB Saunders Co., Philadelphia1978
• Kidney Disease: Hematologic and Vascular Problems 
  Page 89 - 105Montgomery RR, Hathaway, WEEditors: RM McIntosh, SJ Guggenheim, RW Schrier.John Wiley & Sons, Inc., New York1977
• Join now to see all

Abstracts/Posters

• Bleeding Phenotype of Murine Bernard Soulier Syndrome is Potentially Corrected by Non-Myeloablative Hematopoietic Stem Cell Transplantation.
  Kanaji S, Fahs SA, Ware J, Montgomery RR, Shi Q, 54th American Society of Hematology Annual Meeting and Exposition, Atlanta, GA, 12/1/2012
• Lentivirus-Mediated Platelet Gene Therapy Corrects Bleeding Diathesis and Induces Immune Tolerance in Murine Hemophilia B Mice.
  Chen Y, Schroeder JA, Kuether EL, Zhang G, Montgomery RR, Shi Q, 54th American Society of Hematology Annual Meeting and Exposition, Atlanta, GA, 12/1/2012
• Genetic Variability of the CLEC4M Endothelial Lectin Receptor Modulates Binding and Internalization of Von Willebrand Factor and Contributes to Variance in Plasma VWF ...
  Swystun LL, Rydz N, Notley C, Riches JJ, Paterson AD, Montgomery RR, James PD, Lillicrap D, 54th American Society of Hematology Annual Meeting and Exposition, Atlanta, GA, 12/1/2012
• VWF Exerts A Protective Effect on FVIII from Inhibitor Inactivation Both In Vitro and In Vivo.
  Shi Q, Kuether EL, Schroeder JA, Perry CL, Fahs SA, Gill JC, Montgomery RR, International Society of Thrombosis and Haemostasis SSC, Liverpool, 1/1/2012
• Platelet Gene Therapy Corrects the Hemophilic Phenotype in Immunocompromised Hemophilia A Mice Transplanted with Genetically Manipulated Human Cord Blood Stem Cells.
  Shi Q, Kuether EL, Fahs SA, Schroeder JA, Montgomery RR, International Society of Thrombosis and Haemostasis SSC, Liverpool, 1/1/2012
• Discrimination Between VWD Subtypes by Quantitative Analysis of VWF Multimer Structure.
  Haberichter SL, Jacobi PM, Endres JL, Covill S, Flood VH, Montgomery RR, Gill JC, Friedman KD, Am J of Hematol, 1/1/2012
• Targeting FVIII Expression to Platelets Induces Immune Tolerance in Hemophilia A Mice with or without Pre-Existing Anti-FVIII Immunity.
  Chen Y, Kuether EL, Schroeder JA, Montgomery RR, Scott DW, Shi Q, Blood, 11/1/2011
• Platelet Gene Therapy Corrects the Hemophilic Phenotype in Immunocompromised Hemophilia A Mice Transplanted with Genetically Manipulated Human Cord Blood Stem Cells.
  Shi Q, Kuether EL, Fahs SA, Schroeder JA, Montgomery RR, Blood, 11/1/2011
• Genetic Variability of the CLEC4M Endothelial Lectin Receptor in Type 1 Von Willebrand Disease.
  Rydz Natalia, Boonyawat B, Riches JJ, Hopman W, Paterson A, Montgomery R, Lillicrap D, James PD, For the ZPMCB-VWD Study Group, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• Identification of the Elusive Mutation Causing the Historical Von Willebrand Disease Type IIC Miami.
  Schneppenheim R, Ledford-Kraemer M, Lavergne J-M, Marschalek R, Montgomery R, Obser T, Oyen F, Sadler JE, Schneppenheim S, Budde U, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• An L1278P Von Willebrand Factor (VWF) Mutation Identified in a Type 1 VWD Patient Causes Reduced VWF Secretion and Increased VWF Clearance.
  Haberichter S, Schroeder JA, Jacobi PM, Gehrand AL, Friedman KD, DiMichele D, Montgomery RR, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• Integrin alphaIIBBeta3 Activation and Internalization in Platelets of Sitosterolemic Mice.
  Kanaji T, Kanaji S, Montgomery RR, Patel SB, Newman PJ, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• Utility of Von Willebrand Factor Collagen Binding Assays (VWD:CB) With Type VI Collagen in the Diagnosis of VWD.
  Flood VH, Haberichter SL, Friedman KD, Lentz SR, Hoffmann RG, Gill JC, Montgomery RR, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• The Assay of Von Willebrand Factor (VWF) Propeptide to Antigen Ratio (VWFPP/VWF) Identifies a Reduced VWF Survival Phenotype in Mice.
  Jacobi PM, Gehrand AL, Fahs SA, Montgomery RR, Johnsen JM, Haberichter SL, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• Amelioration of Murine VWD by Platelet-Specific Expression of VWF.
  Kanaji S, Fahs SA, Shi Q, Haberichter SL, Montgomery RR, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• Reference Interval for Factor VIII to Von Willebrand Factor Antigen is Lower for Infants under 6 Months of Age Compared to Older Children and Adults.
  Punzalan R, Gill JC, Montgomery RR, Haberichter SL, Friedman KD, XXIII Congress The International Society on Thrombosis and Haemostasis, Kyoto, Japan, 7/1/2011
• Platelet Activation, P-selectin Mmobilization, and Eosinophil Beta 1 Integrin Activation Occur in Asthma and are Associated with Clinical Phenotypes.
  Johnasson MW, Han S-T, Gunderson KA, Montgomery RR, Busse WW, Jarjour NN, Mosher DF, American Thoracic Society Meeting, Denver, CO, 5/1/2011
• Platelet-Based Gene Therapy of Hemophilia A and B.
  Montgomery RR, Shi Q, Zhang G, World Federation of Hemophilia, Buenos Aires, Argentina, 1/1/2010
• Von Willebrand Disease Caused by Accelerated Clearance of VWF.
  Montgomery RR, Haberichter SL, World Federation of Hemophilia, Buenos Aires, Argentina, 1/1/2010
• Fourteen Percent of Healthy African Americans Participating in the Zimmerman Program for the Molecular and Clinical Biology of VWD (ZPMCB-VWD) are Heterozygous for the...
  Friedman KD, Bellissimo DB, Christopherson PA, Flood VH, Gill JC, Montgomery RR, Haberichter SL, and the Primary Clinical Site Directors, American Society of Hematology, Orlando, FL, 1/1/2010
• Factor VIII Inhibitors: Von Willebrand Factor Makes a Difference In Vitro and In Vivo.
  Shi Q, Kuether EL, Schroeder JA, Perry CL, Fahs SA, Montgomery RR, American Society of Hematology, Orlando, FL, 1/1/2010
• The Important Role of Von Willebrand Factor in Platelet-Derived FVIII Gene Therapy of Murine Hemophilia A in the Presence of Inhibitors.
  Shi Q, Kuether EL, Schroeder JA, Fahs SA, Wilcox DA, Montgomery RR, American Society of Hematology, Orlando, FL, 1/1/2010
• Correction of Murine Bernard Soulier Syndrome by Lentivirus-mediated Gene Therapy.
  Kanaji S, Kuether EL, Fahs SA, Schroeder JA, Ware J, Montgomery RR, Shi Q, American Society of Hematology, Orlando, FL, 1/1/2010
• VWF Binding to Types I, III, or VI Collagen in the ZPMCB-VWD with Identification of Subjects with Selective Reduced Plasma VWF:CB.
  Flood VH, Haberichter SL, Friedman KD, Lentz SR, Gill JC, Montgomery RR, American Society of Hematology, Orlando, FL, 1/1/2010
• Low VWF:RCo in Subjects with VWF Polymorphisms D1472H and P1467S Due to Decreased Binding of Ristocetin to the VWF A1 Domain.
  Flood VH, Wren JS, Haberichter SL, Friedman KD, Bellissimo DB, Gill JC, Hoffmann RG, Scott JP, Montgomery RR, American Society of Hematology, Orlando, FL, 1/1/2010
• Join now to see all

Lectures

• "Minimum or extensive VWD investigation in clinical routine" 
  Melbourne, Australia - 5/15/2014
• "What Is VWD and Why Do I Bleed" 
  Phoenix, AZ - 2/21/2014
• "Diagnosis of Von Willebrand Disease" 
  Mazatlan, Mexico - 4/29/2013
• Visiting Professor, "The Fidelity of VWD Diagnosis" 
  Center for Blood Research, Diamond Health Care Centre, Vancouver, British Columiba, Canada - 3/5/2013
• Visiting Professor, "Platelet Targeted Gene Therapy for Hemophilia" 
  Centre Blood Research, Vancouver, British Columbia, Canada - 3/5/2013
• "Laboratory and Translational Hematology-Trainee Career Development Lunch" 
  Atlanta, GA - 12/1/2012
• "Measuring VWF-Gp1b Binding: Potential for Better Understanding of VWF Functionality compared to RiCoF?" 
  Mariehamm, the Aland Islands, Finland - 9/26/2012
• "Zimmerman Project (ZPMCB-VWD)" 
  Liverpool, United Kingdom - 6/30/2012
• "Von Willebrand Disease" 
  Liverpool, United Kingdom - 6/27/2012
• "Fidelity of VWD Testing" 
  Milwaukee, WI - 5/31/2012
• Spaet Visiting Professor, "The Fidelity of the Diagnosis of Von Willebrand Disease" 
  Montefiore Medical Center, The Albert Einstein College of Medicine, Bronx, NY - 5/17/2012
• "Non-Hepatic Expression of Clotting Factors" 
  Chapel Hill, NC - 5/5/2012
• "Diagnosis and Treatment of von Willebrand Disease" 
  Santiago, Chile - 4/12/2012
• "Pathophysiology of von Willebrand Disease" 
  Santiago, Chile - 4/12/2012
• "VWF Function: A Laboratory Perspective" 
  Miami, FL - 3/22/2012
• "Genes and Platelets 
  London, United Kingdom - 1/8/2012
• "Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD" 
  San Diego, CA - 12/12/2011
• "Hemophilias and von Willebrand Disease" 
  Cascais, Portugal - 11/7/2011
• Invited Participant: "Inaugural Bayer Hemophilia Care Innovation Summit" 
  Budapest, Hungary - 10/13/2011
• "von Willebrand Factor and von Willebrand Disease" 
  Kyoto, Japan - 7/26/2011
• "Zimmerman Project (ZPMCB-VWD) Update on Activities" 
  Kyoto, Japan - 7/24/2011
• "The Fidelity of VWD Diagnosis" 
  Waltham, MA - 6/7/2011
• "The Trojan Horse Approach to Gene Therapy of Hemophilia A and B" 
  Waltham, MA - 6/7/2011
• "von Willebrand Disease-Case Presentations" 
  Nichols Institute/Quest Diagnostics, Newport Beach, CA - 6/2/2011
• "Fidelity of VWD Diagnosis-from ristocetin to collagen" 
  Pugnochiuso, Vieste, Italy - 5/1/2011
• Join now to see all

Other

• The Diagnosis, Evaluation, and Management of von Willebrand Disease 
  Nichols WL Jr, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP, U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, a
  12/1/2007
• "Blood Coagulation & Fibrinolysis, Vol 16 Suppl 1, Lippincott Williams & Wilkins" (Guest Editors) 
  Lee CA, Montgomery RR
  4/1/2005
• Understanding von Willebrand Disease. 
  Montgomery RR, Hilgartner MW, The National Hemophilia Foundation
  New York - 1/1/1991
• Clinical and laboratory abnormalities of factor VIII and von Willebrand factor. 
  Montgomery RR, Symposium on Hemostasis and Thrombosis, Ortho Diagnostics
  1/1/1989
• Join now to see all